Global Patent Index - EP 3500583 A1

EP 3500583 A1 20190626 - PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY

Title (en)

PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY

Title (de)

REINE HEPTASULFATIERTE DISACCHARIDE MIT VERBESSERTER ORALER BIOVERFÜGBARKEIT

Title (fr)

DISACCHARIDES HEPTASULFATÉS PURS À BIODISPONIBILITÉ ORALE AMÉLIORÉE

Publication

EP 3500583 A1 20190626 (EN)

Application

EP 17757990 A 20170814

Priority

  • US 201662375528 P 20160816
  • US 2017046774 W 20170814

Abstract (en)

[origin: WO2018035050A1] Hypersulfated disaccharides with utility in asthma or asthma related disorders are disclosed. The heptasulfated disaccharides administered orally have comparable bioavailability to the intravenous administered dosage form.

IPC 8 full level

C07H 1/00 (2006.01); A61K 9/00 (2006.01); A61K 31/7024 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 29/00 (2006.01); C07H 11/00 (2006.01)

CPC (source: EP IL US)

A61K 9/0019 (2013.01 - EP IL US); A61K 9/0053 (2013.01 - IL US); A61K 9/007 (2013.01 - IL US); A61K 9/0073 (2013.01 - EP IL US); A61K 9/0095 (2013.01 - IL); A61K 31/7024 (2013.01 - EP IL US); A61P 37/08 (2018.01 - EP IL US); C07H 1/00 (2013.01 - EP IL US); C07H 11/00 (2013.01 - EP IL US); A61K 9/0095 (2013.01 - EP US); C07B 2200/13 (2013.01 - IL US)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2018035050 A1 20180222; EP 3500583 A1 20190626; IL 264851 B 20211201; TW 201815394 A 20180501; US 10829509 B2 20201110; US 2019185503 A1 20190620; US 2021009620 A1 20210114

DOCDB simple family (application)

US 2017046774 W 20170814; EP 17757990 A 20170814; IL 26485119 A 20190214; TW 106127418 A 20170814; US 201716325940 A 20170814; US 202017028109 A 20200922